Avery W Catlin's Net Worth
$11 Million
Who is Avery W Catlin?
Avery W Catlin has an estimated net worth of $11 Million. This is based on reported shares across multiple companies, which include Provention Bio, Inc., Corbus Pharmaceuticals Holdings, Inc., and AVANT IMMUNOTHERAPEUTICS INC.
SEC CIK
Avery W Catlin's CIK is 0001255348
Past Insider Trading and Trends
2015 was Avery W Catlin's most active year for acquiring shares with 10 total transactions. Avery W Catlin's most active month to acquire stocks was the month of April. 2023 was Avery W Catlin's most active year for disposing of shares, totalling 6 transactions. Avery W Catlin's most active month to dispose stocks was the month of March. 2013 saw Avery W Catlin paying a total of $1,498,972.28 for 273,833 shares, this is the most they've acquired in one year. In 2013 Avery W Catlin cashed out on 366,666 shares for a total of $4,491,658.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Provention Bio, Inc. No price found
InvestorAvery W Catlin owns 10,000 units of Common Stock. In the year 2018 Avery W Catlin filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.00K |
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
| 20K |
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +100.00% | 10K |
$1.88 | $18,750.00 | 20K |
Dec 24 - Dec 26
| |||
Form 4
|
∞
| 10K |
$3.15 | $31,500.00 | 10K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04
InvestorAvery W Catlin owns 47,000 units of Common Stock which is worth $2,351,880.00 and 4,350 units of Common Stock, par value $0.0001 per share which is worth $217,674.00. From 2014 to 2024 Avery W Catlin acquired a total of 49,783 shares in Corbus Pharmaceuticals Holdings, Inc. at a cost of $146,285.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +177.60% | 2.78K |
—
|
—
| 4.35K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +11.90% | 5K |
$6.15 | $30,740.50 | 47K |
May 11
| |||
Form 4
| +5.00% | 2K |
$7.55 | $15,100.00 | 42K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +25.83% | 8.21K |
$1.90 | $15,602.80 | 40K |
Aug 18
| |||
Form 4
| +58.94% | 11.79K |
$1.94 | $22,842.20 | 31.79K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
∞
| 20K |
$3.10 | $62,000.00 | 20K |
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANT IMMUNOTHERAPEUTICS INC (CLDX) Snapshot price: $44
Sr. VP & CFOAvery W Catlin owns 35,109 units of Common Stock which is worth $1,544,796.00 and 83,586 units of Common Stock, par value $0.001 per share which is worth $3,677,784.00.acquired a total of 328,148 shares in AVANT IMMUNOTHERAPEUTICS INC at a cost of $2,192,163.48, Avery also disposed a total of 233,333 shares of AVANT IMMUNOTHERAPEUTICS INC equalling to $5,556,411.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.59% | 10K |
$2.80 | $28,000.00 | 83.59K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +45.03% | 22.85K |
$3.01 | $68,811.50 | 73.59K |
Jun 3
| |||
Form 4
| +41.97% | 15K |
$2.80 | $42,000.00 | 50.74K |
Mar 9
| |||
Form 4
|
—
|
0
|
$13.26 | -$237,000.00 | 35.11K |
Scheduled
|
Nov 23
| ||
Form 4
| +39.83% | 10K |
$4.50 | $45,000.00 | 35.11K |
Sep 11
| |||
Form 4
|
—
|
0
|
$16.56 | -$401,752.50 | 24.61K |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +68.45% | 10K |
$4.50 | $45,000.00 | 24.61K |
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
$16.33 | -$2,995,661.22 | 14.11K |
Dec 6
| |||
Form 4
| +3.67% | 500 |
$5.95 | $2,975.00 | 14.11K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 2K |
$2.39 | $4,780.00 | 2K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 4
|
∞
| 2K |
$3.51 | $7,016.00 | 2K |
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
∞
| 1K |
$4.41 | $4,408.00 | 1K |
Nov 30
| |||
Form 4
| +310.31% | 5.87K |
—
|
—
| 7.76K |
Jan 6
| |||
Form 4
|
∞
| 100 |
$6.73 | $673.20 | 100 |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +2.38% | 500 |
$0.71 | $352.75 | 21.5K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +31.25% | 5K |
$1.35 | $6,750.00 | 21K |
Aug 16
| |||
Form 4
| +3.23% | 500 |
$1.37 | $684.50 | 16K |
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +47.62% | 5K |
$1.14 | $5,700.00 | 15.5K |
Nov 22
| |||
Form 4
| +5.00% | 500 |
$0.99 | $497.25 | 10.5K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +53.85% | 3.5K |
$1.83 | $6,387.50 | 10K |
Aug 3
| |||
Form 4
| +8.33% | 500 |
$2.26 | $1,130.50 | 6.5K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||